Wafa Tombari | Vaccines | Best Researcher Award

Published on by Infectious

Assist. Prof. Dr. Wafa Tombari | Vaccines | Best Researcher Award

Assistant Professor | University Hospital of Sahloul | Tunisia

Dr. Wafa Tombari, Ph.D., is an accomplished Assistant Professor and Research Scientist at the University Hospital of Sahloul, Sousse, specializing in infectious diseases with a focus on virology, vaccine development, and antimicrobial resistance. She holds a Doctoral Diploma in Biology from the Faculty of Sciences in Tunisia, a Master of Science in Microbiology, and a Certificate of Complementary Studies in Statistics and Epidemiological Methods from the Faculty of Medicine in Tunisia. With a distinguished academic and research career, Dr. Tombari has served as an Assistant Professor at both the High Institute of Medical Technologies and the University Hospital of Sahloul, where she has successfully led and collaborated on numerous national and international research projects. Her research integrates molecular biology, bioinformatics, and immunoinformatics to develop computational approaches for vaccine design, antiviral therapeutics, and the study of bacterial resistance mechanisms. She has authored several peer-reviewed publications in reputable international journals, including studies on mRNA-based vaccines for rabies virus and molecular characterization of antimicrobial resistance in Staphylococcus species, highlighting her contributions to advancing biomedical innovation. Beyond her research, Dr. Tombari plays an active role in student mentorship, curriculum development, and scientific outreach, fostering collaboration and innovation within the academic community. Her expertise extends to reverse vaccinology, molecular cloning, and phylogenetic analysis, reflecting her multidisciplinary approach to infectious disease research. Dr. Tombari’s scholarly achievements and professional dedication exemplify her commitment to advancing global health through science and education. She has achieved 119 citations, published 10 scientific documents, and holds an h-index of 5, reflecting her academic influence and research excellence.

Profiles: Scopus | Google Scholar

Featured Publications

1. Tombari, W., Nsiri, J., Larbi, I., Guerin, J. L., & Ghram, A. (2011). Genetic evolution of low pathogenicity H9N2 avian influenza viruses in Tunisia: . Acquisition of new mutations. Virology Journal, 8(1), 467.

2. Tombari, W., Paul, M., Bettaieb, J., Larbi, I., Nsiri, J., Elbehi, I., Gribaa, L., & Ghram, A. (2013). Risk factors and characteristics of low pathogenic avian influenza virus isolated from commercial poultry in Tunisia. PLoS ONE, 8(1), e53524.

3. Boudaoud, A., Mamache, B., Tombari, W., & Ghram, A. (2016). Virus mutations and their impact on vaccination against infectious bursal disease (Gumboro disease). Revue Scientifique et Technique, 35(3), 875–897.

4. Kallel Sellami, M., Zitouni, M., Tombari, W., Ben Ayed, M., Abida, O., Laadhar, L., et al. (2007). Anti-desmoglein-1 antibodies are prevalent in Tunisian patients with hydatidosis and leishmaniasis. British Journal of Dermatology, 156(3), 591–593.

Albert Eisenbarth | Infectious Diseases Prevention | Best Researcher Award

Published on by Infectious

Dr. Albert Eisenbarth | Infectious Diseases Prevention | Best Researcher Award

Head of Medical Entomology Unit | Bundeswehr Hospital Hamburg | Germany

Albert Eisenbarth is an accomplished researcher at the Bundeswehr Hospital Hamburg, Germany, specializing in infectious diseases, tropical medicine, and vector biology. He holds a Ph.D. in Medical Biology from the University of Hamburg  where his doctoral work focused on the ecology and control of mosquito-borne pathogens. Over the years, Dr. Eisenbarth has gained extensive professional experience leading and collaborating on multidisciplinary research projects across Europe and Africa, particularly in the molecular detection and epidemiology of parasitic and vector-borne diseases. His research interests encompass mosquito ecology, disease transmission modeling, public health interventions, and the application of artificial intelligence in entomological studies. Dr. Eisenbarth possesses strong research skills in molecular biology, field entomology, data analytics, and bioinformatics, which he applies to enhance disease surveillance and vector control programs. His collaborative approach and scientific leadership have contributed to the success of international initiatives investigating malaria, leishmaniasis, and arbovirus transmission. A dedicated academic and mentor, he has co-authored numerous peer-reviewed papers published in reputed journals such as Scientific Data, Acta Tropica, and Travel Medicine and Infectious Disease. His contributions to research excellence have earned him recognition within the scientific community, including invitations to present at international symposia and participate in global health research networks. Dr. Eisenbarth’s continuing commitment to bridging field research with applied innovations reflects his passion for advancing global public health outcomes. His long-term vision involves fostering stronger international collaborations and mentoring early-career scientists in tropical disease research. Through his scholarly achievements and leadership, he continues to make a meaningful impact in biomedical research and public health policy.Dr. Albert Eisenbarth has an impressive academic record with 418 citations across 31 published documents and an h-index of 14, reflecting the strong impact and consistency of his research contributions in infectious diseases and vector biology.


Profiles : ORCID | Scopus

Featured Publications

1. Nolte, K., Agboli, E., Garcia, G. A., Badolo, A., Becker, N., Loc, D. H., Dworrak, T. V., Eguchi, J., Eisenbarth, A., de Freitas, R. M., et al. (2025). Comprehensive mosquito wing image repository for advancing research on geometric morphometric- and AI-based identification.

2. Lubbers, C., Amaral, L.-J., Colebunders, R., Brattig, N., Hadermann, A., & Eisenbarth, A. (2025, October). The last mile in onchocerciasis elimination: Diagnostic challenges.

3. Krüger, A., Balczun, C., Scheid, P. L., Hagen, R. M., & Eisenbarth, A. (2023). Molecular detection of Leishmania (Sauroleishmania) adleri (Trypanosomatida: Trypanosomatidae) in Sergentomyia sp. sand flies (Diptera: Psychodidae) in Mali and Niger.

4. Stoek, F., Barry, Y., Ba, A., Schulz, A., Rissmann, M., Wylezich, C., Sadeghi, B., Beyit, A. D., Eisenbarth, A., N’diaye, F. B., et al. (2022, April 15). Mosquito survey in Mauritania: Detection of Rift Valley fever virus and dengue virus and the determination of feeding patterns.

5. Ngwasiri, N. N., Brattig, N. W., Ndjonka, D., Liebau, E., Paguem, A., Leusder, D., Kingsley, M. T., Eisenbarth, A., Renz, A., & Daniel, A. M. (2021). Correction to: Galectins from Onchocerca ochengi and O. volvulus and their immune recognition by Wistar rats, Gudali zebu cattle and human hosts.

 

 

Lata Deso Abo | Development of New Vaccines | Best Researcher Award

Published on by Infectious

Mr. Lata Deso Abo | Development of New Vaccines | Best Researcher Award

Lecturer and Researcher | Haramaya University, Haramaya Institute of Technology | Ethiopia

Lata Deso Abo is a Lecturer and Researcher in the Department of Chemical Engineering at Haramaya Institute of Technology, Haramaya University, Ethiopia. He earned his Bachelor of Science degree in Chemical Engineering/Process Engineering from Haramaya University in 2017, followed by a Master of Science in Chemical Engineering with a specialization in Bioenergy Engineering from Addis Ababa Science and Technology University in 2021. His research focuses on sustainable technologies, bioenergy, waste valorization, green innovations, and advanced water treatment, with a particular emphasis on bioethanol production, biomass utilization, and the mitigation of industrial fouling in heat transfer systems. Lata has published extensively in reputable journals including Thermal Science Engineering Progress, Environmental Quality Management, Fuel, Chemosphere, and Results in Engineering, contributing studies on heat exchanger fouling, bioethanol optimization through artificial neural networks, biowaste valorization, and the development of eco-friendly biopesticides. His work has also been presented at international conferences such as EPACT-2022 and the AIP Conference Proceedings. In recognition of his scholarly contributions, he has received multiple awards and certificates for teaching performance, research excellence, and editorial reviewing roles in journals like Results in Engineering, Biomass and Bioenergy, and Journal of Environmental Management. Proficient in English and Amharic, and skilled in computational and chemical engineering tools including Aspen Plus, SuperPro Designer, MATLAB, CHEMCAD, and R programming, Lata Deso Abo combines research, teaching, and innovation to advance chemical engineering knowledge and sustainable solutions, making him a distinguished contributor to both academia and applied engineering research. He has 38 citations from 2 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Chozhavendhan, S., Karthigadevi, G., Bharathiraja, B., Kumar, R. P., Abo, L. D., … (2023). Current and prognostic overview on the strategic exploitation of anaerobic digestion and digestate.

2. Jayakumar, M., Hamda, A. S., Abo, L. D., Daba, B. J., Prabhu, S. V., Rangaraju, M., … (2023). Comprehensive review on lignocellulosic biomass derived biochar production, characterization, utilization and applications.

3. Jayakumar, M., Gebeyehu, K. B., Abo, L. D., Tadesse, A. W., Vivekanandan, B., … (2023). A comprehensive outlook on topical processing methods for biofuel production and its thermal applications.

4. Areti, H. A., Muleta, M. D., Abo, L. D., Hamda, A. S., Adugna, A. A., Edae, I. T., Daba, B. J., … (2024). Innovative uses of agricultural by-products in the food and beverage sector.

5. Gari, M. T., Asfaw, B. T., Arumugasamy, S. K., Abo, L. D., … (Year). Natural resources-based activated carbon synthesis.

Mr. Malvern Munjoma | Prophylaxis | Best Researcher Award

Published on by Infectious

Mr. Malvern Munjoma | Prophylaxis | Best Researcher Award

Population Solutions for Health | Zimbabwe.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

From his formative years, Mr. Malvern Munjoma exhibited an exceptional passion for biomedical sciences and public health advocacy. He began his academic journey with a Bachelor’s degree in Biomedical Sciences, where he built a strong foundation in microbiology, immunology, and clinical diagnostics. He then advanced to specialize in infectious disease research, focusing on the mechanisms of disease transmission and preventive strategies—a pathway that would later define his impactful career in prophylactic medicine.

💼PROFESSIONAL ENDEAVORS

Throughout his professional career, Mr. Munjoma has served in public health institutions, research organizations, and clinical laboratories across Southern Africa. His roles have included infectious disease specialist, clinical research associate, and public health educator. His work consistently bridges the gap between clinical evidence and community-based healthcare, emphasizing disease prevention, early intervention, and health policy development.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON PROPHYLAXIS

Mr. Munjoma’s most notable contributions lie in the field of prophylaxis—the science of preventing disease before it occurs. His research spans:

  • Pre-exposure prophylaxis (PrEP) in HIV prevention

  • Tuberculosis prophylaxis in high-risk populations

  • Vaccination efficacy and hesitancy in underserved communities

  • Community-based prophylactic outreach models

His work has shaped regional health strategies and led to the implementation of low-cost preventive programs in rural settings. His voice is also central in promoting ethical and accessible preventive healthcare, especially among marginalized populations.

🌍IMPACT AND INFLUENCE

Mr. Munjoma’s influence extends beyond research. He is a trusted advisor to health ministries, a contributor to public health campaigns, and a mentor to young scientists. His projects have directly impacted disease control efforts across Sub-Saharan Africa, influencing vaccination coverage, HIV/AIDS reduction programs, and community prophylaxis awareness. His ability to combine rigorous science with grassroots impact defines his leadership in global health resilience.

🏆RESEARCH GRANTS AND FUNDING

Mr. Munjoma has successfully led and contributed to projects funded by:

  • The Global Fund to Fight AIDS, Tuberculosis and Malaria

  • USAID HIV and AIDS Programs

  • African Academy of Sciences (AAS) Research Fellowships

🦠LEGACY AND FUTURE CONTRIBUTIONS

As a forward-thinking researcher, Mr. Munjoma is committed to driving innovations in disease prediction, preventive genomics, and digital health tools for community-based surveillance. His mentorship of aspiring public health leaders ensures a legacy of scientific integrity and societal transformation. He is currently working on a region-wide prophylaxis integration model aimed at reducing disease burdens across Southern Africa by 2030.

🌟A VISIONARY IN INFECTIOUS DISEASES

Mr. Malvern Munjoma stands as a visionary in the field of infectious diseases, with a focus that is not only scientific but deeply humanitarian. His work embodies a mission to protect, educate, and empower—positioning him as one of the most respected voices in disease prevention and global health security.

📑NOTABLE PUBLICATIONS

Acceptability and feasibility of implementing thermal ablation as a preventive cervical cancer treatment and the comparison of treatment outcome with cryotherapy in Zimbabwe

Authors: Malvern Munjoma, Stephano Gudukeya, Jabulani Mavudze, Staci Leuschner, Noah Taruberekera

Publication Year: 2024

Journal: ecancermedicalscience

A mixed-method study of feasibility and acceptability of the Dapivirine vaginal ring among adolescent girls and young women (AGYW) in selected Zimbabwean districts

Authors: Noah Taruberekera, Tsitsi B. Masvawure, Malvern Munjoma, Owen Mugurungi, Getrude Ncube, Miriam Mutseta, Munyaradzi Dhodho, Hanul Choi, Jabulani Mavudze, Tafara Moga, et al.

Publication Year: 2025

Journal: PLOS Global Public Health

Gerardo Guillen Nieto | Pandemic preparedness | Best Researcher Award

Published on by Infectious

Gerardo Guillen Nieto | Pandemic preparedness | Best Researcher Award

Prof Dr. Gerardo Guillen Nieto, Center for Genetic Engineering and Biotechnology, Cuba.

Dr. Gerardo Guillen Nieto is a distinguished researcher specializing in pandemic preparedness and infectious disease management. Renowned for his innovative work in vaccine development and immunology, Dr. Guillen has significantly contributed to global health initiatives, leading critical studies that have informed public health policies and improved response strategies for emerging infectious threats. His dedication to advancing medical research and his impactful publications have earned him prestigious recognitions, including the Best Researcher Award for his exemplary contributions to pandemic readiness and prevention.

Profile:

Orcid  Profile

Education

Dr. Gerardo Guillen Nieto holds a B.Sc. in Chemistry (1986) and an M.Sc. in Organic Chemistry from Odessa University, Ukraine, and earned his Ph.D. in Biological Sciences from Havana University in 1995. He has been recognized as a Senior Researcher since 2001 and was appointed Full Professor at Havana University in 2018 and at the Latin American School of Medicine in 2019. His exceptional career also includes being named a Distinguished Professor-at-Large at the University of Electronic Science and Technology of China in 2018. Dr. Guillen is a respected member of both the Cuban Academy of Science (since 2012) and the World Academy of Science (since 2022), showcasing his international acclaim and contributions to the field.

 

Experience 

Since 1998, Dr. Gerardo Guillen Nieto has held the prominent position of Director of Biomedical Research at the Center for Genetic Engineering and Biotechnology in Havana, Cuba. In this role, he has led groundbreaking research initiatives, overseeing a wide range of projects focused on genetic engineering and biotechnological advancements that have had a substantial impact on public health and biomedical sciences both nationally and internationally.

 

Conclusion

In conclusion, Dr. Gerardo Guillen Nieto’s extensive career is marked by profound contributions to the fields of vaccine development and biotechnological research, showcasing a commitment to advancing global health. His leadership at the Center for Genetic Engineering and Biotechnology, along with his academic roles and membership in prestigious scientific organizations, underscore his influence in scientific innovation and education. Dr. Guillen’s impressive body of work, recognized through numerous awards and over 270 published scientific articles, highlights his dedication to combating some of the most pressing medical challenges of our time. His expertise and contributions have left an indelible mark on both the scientific community and public health initiatives worldwide.

Top Note Publications

Title: Carcinogenic Effect of Human Tumors-Derived Cell Free-Filtrates in Nude Mice

Authors: Gerardo Guillen et al.
Journal: Preprint
Year: 2023

Title: The effects of Phycocyanobilin on experimental arthritis involve the reduction in nociception and synovial neutrophil infiltration, inhibition of cytokine production, and modulation of the neuronal proteome

Authors: Gerardo Guillen et al.
Journal: Frontiers in Immunology
Year: 2023

Title: Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders

Authors: Gerardo Guillen et al.
Journal: Vaccines
Year: 2023

Title: Endogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence: Hypothetical Reflections

Authors: Gerardo Guillen et al.
Journal: International Journal of Molecular Sciences
Year: 2023

Title: Reflections on Endogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence

Authors: Gerardo Guillen et al.
Journal: Preprint
Year: 2023